Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1986 Dec 1;164(6):1973–1987. doi: 10.1084/jem.164.6.1973

Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis

PMCID: PMC2188498  PMID: 3537193

Abstract

We investigated the effect of proteolytic enzyme treatment on the course of passive Heymann nephritis (PHN). PHN was induced by intravenous injection of Heymann antibody into Sprague Dawley rats. Protease-treated rats received intraperitoneal chymopapain and subtilisin. In rats given subnephritogenic doses of Heymann antibody (5 or 10 mg, insufficient to cause proteinuria), glomerular immune deposits were assessed by immunofluorescence and electron microscopy. In rats given 5 mg Heymann antibody and treated with protease in the heterologous phase of the disease (days 1-7), fewer animals were positive for rabbit IgG and rat IgG, as determined by immunofluorescence on day 12, compared with controls (p less than 0.01). Rats given 10 mg Heymann antibody and treated on days 1-5 were less frequently positive for rabbit IgG on day 5 than controls (p less than 0.05). When treatment was given on days 6-12 (autologous phase), fewer rats had glomerular rabbit and rat IgG compared with controls (p less than 0.025). Protease treatment of rats given nephritogenic doses of Heymann antibody (greater than or equal to 40 mg, causing proteinuria) did not result in significant differences in immunofluorescence deposits. However, protease treatment significantly reduced the number of electron dense deposits at all doses of antibody (p less than 0.01). Furthermore, rats given 60 mg Heymann antibody followed by enzyme treatment in the heterologous phase (days 1-7) or throughout the autologous phase (days 6-18) had significantly reduced protein excretion during the autologous phase compared with control rats (p less than 0.05). After onset of significant proteinuria on day 15 in rats given 40 mg Heymann antibody and treated from day 15 until day 25, there was significantly less (p less than 0.05) proteinuria on days 21-22 and 24-25 than in control rats; thus, enzymes could reverse proteinuria. In normal rats, administration of proteases did not have significant effects on urinary protein excretion, serum creatinine, or renal morphology, nor did protease affect anti-rabbit IgG antibody production in rats injected with Heymann antibody. The overall results indicate that proteolytic enzyme treatment can prevent or remove glomerular immune deposits and can prevent or reverse proteinuria.

Full Text

The Full Text of this article is available as a PDF (1,011.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barabas A. Z., Nagi A. H., Lannigan R., Womersley R. A. The effect of cortisone treatment on autologous immune complex glomerulonephritis in rats. Br J Exp Pathol. 1970 Dec;51(6):541–546. [PMC free article] [PubMed] [Google Scholar]
  2. Bartolotti S. R., Peters D. K. Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness. Clin Exp Immunol. 1978 May;32(2):199–206. [PMC free article] [PubMed] [Google Scholar]
  3. Bolton W. K., Spargo B. A., Lewis E. J. Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. J Lab Clin Med. 1974 May;83(5):695–704. [PubMed] [Google Scholar]
  4. Couser W. G., Steinmuller D. R., Stilmant M. M., Salant D. J., Lowenstein L. M. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest. 1978 Dec;62(6):1275–1287. doi: 10.1172/JCI109248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edgington T. S., Glassock R. J., Dixon F. J. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med. 1968 Mar 1;127(3):555–572. doi: 10.1084/jem.127.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feenstra K., van den Lee R., Greben H. A., Arends A., Hoedemaeker P. J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. II. Influence of medication with prednisone and azathioprine: a histologic and immunohistologic study at the light microscopic and the ultrastructural level. Lab Invest. 1975 Feb;32(2):243–250. [PubMed] [Google Scholar]
  7. Gallo G. R., Caulin-Glaser T., Emancipator S. N., Lamm M. E. Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge. Lab Invest. 1983 Mar;48(3):353–362. [PubMed] [Google Scholar]
  8. Gallo G. R., Caulin-Glaser T., Lamm M. E. Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest. 1981 May;67(5):1305–1313. doi: 10.1172/JCI110159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garovoy M. R., Kupor L. R., Mullins J. D., McPhaul J. J., Jr Treatment of autologous immune complex glomerulonephritis with vasoactive amine antagonists. J Lab Clin Med. 1977 Oct;90(4):638–644. [PubMed] [Google Scholar]
  10. HEYMANN W., HUNTER J. L., HACKEL D. B. Experimental auto-immune nephrosis in rats: III. J Immunol. 1962 Feb;88:135–141. [PubMed] [Google Scholar]
  11. Haakenstad A. O., Striker G. E., Mannik M. Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Lab Invest. 1983 Mar;48(3):323–331. [PubMed] [Google Scholar]
  12. Kano K., Milgrom F. Immune complex disease. Vox Sang. 1980;38(3):121–137. doi: 10.1111/j.1423-0410.1980.tb02340.x. [DOI] [PubMed] [Google Scholar]
  13. Kerjaschki D., Farquhar M. G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med. 1983 Feb 1;157(2):667–686. doi: 10.1084/jem.157.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kerjaschki D., Farquhar M. G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5557–5561. doi: 10.1073/pnas.79.18.5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lim V. S., Spargo B. Immunosuppressive treatment of autologous immune complex nephritis in rats. J Lab Clin Med. 1973 May;81(5):661–670. [PubMed] [Google Scholar]
  16. Lotan D., Kaplan B. S., Fong J. S., Goodyer P. R., de Chadarevian J. P. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis. Kidney Int. 1984 May;25(5):778–788. doi: 10.1038/ki.1984.90. [DOI] [PubMed] [Google Scholar]
  17. Makker S. P. Heymann nephritis of rats: beneficial effect of methysergide. J Lab Clin Med. 1977 Nov;90(5):796–802. [PubMed] [Google Scholar]
  18. Mannik M., Striker G. E. Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest. 1980 May;42(5):483–489. [PubMed] [Google Scholar]
  19. OWEN J. A., IGGO B., SCANDRETT F. J., STEWART C. P. The determination of creatinine in plasma or serum, and in urine; a critical examination. Biochem J. 1954 Nov;58(3):426–437. doi: 10.1042/bj0580426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Penner E., Albini B., Glurich I., Andres G. A., Milgrom F. Dissociation of immune complexes in tissue sections by excess of antigen. Int Arch Allergy Appl Immunol. 1982;67(3):245–253. doi: 10.1159/000233026. [DOI] [PubMed] [Google Scholar]
  21. Rosen S. Membranous glomerulonephritis: current status. Hum Pathol. 1971 Jun;2(2):209–231. doi: 10.1016/s0046-8177(71)80035-7. [DOI] [PubMed] [Google Scholar]
  22. Salant D. J., Belok S., Madaio M. P., Couser W. G. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest. 1980 Dec;66(6):1339–1350. doi: 10.1172/JCI109987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sugisaki T., Shiwachi S., Ito S., Yonekura M., Kitazawa K., Yamamoto J., Uchida J., Kawasumi H., Sato K., Shibata T. [High-dose gamma globulin therapy for membranous nephropathy, membranoproliferative glomerulonephritis and lupus nephritis]. Nihon Jinzo Gakkai Shi. 1983 Jun;25(6):697–708. [PubMed] [Google Scholar]
  24. Van Damme B. J., Fleuren G. J., Bakker W. W., Vernier R. L., Hoedemaeker P. J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest. 1978 Apr;38(4):502–510. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES